Ross\Johnson & Associates’s Cognizant CTSH Stock Holding History

Ross\Johnson & Associates’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$664	–	248
2025 Q4	$664	Buy	+8	New	+$599	0.01%	122
2025 Q2	–	Sell	-22	Closed	-$1.68K	–	238
2025 Q1	$1.68K	Buy	+22	New	+$1.79K	0.03%	182

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ross\Johnson & Associates's CTSH Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 8 shares — an estimated $664 sold.

Ross\Johnson & Associates first reported a position in CTSH in Q1 2025 and held it in 2 quarters. The position peaked at $1.68K in Q1 2025. 995 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Ross\Johnson & Associates reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
Ross\Johnson & Associates sold 8 Cognizant shares in Q1 2026, an estimated $664.
Ross\Johnson & Associates first reported a position in Cognizant in Q1 2025 and held it in 2 quarters.
Ross\Johnson & Associates's Cognizant position peaked at $1.68K in Q1 2025.
995 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.